Filtered By:
Therapy: Dialysis
This page shows you your search results in order of date. This is page number 20.
Order by Relevance | Date
Total 2040 results found since Jan 2013.
A systematic review and meta-analysis of efficacy and safety of Calcimimetic agents in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease
CONCLUSION: Calcimimetic agents can reduce the PTH level, Ca level, P level, calcium-phosphorus product level and do not increase the serious adverse events.PMID:36305135 | DOI:10.2174/1381612829666221027110656
Source: Current Pharmaceutical Design - October 28, 2022 Category: Drugs & Pharmacology Authors: Yiping Liu Qian Yang Guangyong Chen Tianbiao Zhou Source Type: research
Acute chest pain and dyspnoea as clinical presentation of primary membranous nephropathy. A case report and literature review
Acta Biomed. 2022 Oct 26;93(5):e2022216. doi: 10.23750/abm.v93i5.12782.ABSTRACTMembranous nephropathy (MN) is the commonest cause of nephrotic syndrome (NS) in adult male patients worldwide. Most of the cases (80%) are idiopathic (primary MN, PMN), whereas about 20% are associated with autoimmune diseases, malignancies or exposures (secondary MN). PMN is a kidney-specific autoimmune glomerular disease mediated by antibodies to the M-type phospholipase A2 receptor (anti-PLA2R) (85%), thrombospondin type 1 domain containing 7A (THSD7A) (3-5%), or by other still unidentified mechanisms (10%). Most of the patients with PMN pre...
Source: Acta Bio-Medica : Atenei Parmensis - October 27, 2022 Category: General Medicine Authors: Erika Poggiali Giorgia Borio Andrea Magnacavallo Andrea Vercelli Gianfranco Cervellin Source Type: research
